Figure 4 | Scientific Reports

Figure 4

From: Eriodictyol attenuates osteoarthritis progression through inhibiting inflammation via the PI3K/AKT/NF-κB signaling pathway

Figure 4

Eriodictyol inhibits IL-1β-induced NF-κB activation and IκBα degradation. Chondrocytes were pretreated with eriodictyol (5, 10, 15 μM) 12 h before IL-1β (10 ng/ml) treatment. 30 min after IL-1β treatment, the cells were collected for western blot analysis. β-actin was used as a control. The values presented are the means ± SEM of three independent experiments. #p < 0.01 versus control group; **p < 0.01 versus IL-1β group.

Back to article page